Activist Investors Target $30 Billion Tied Up in Biotech Stocks
Published on July 21, 2025
Every so often, activist investors swarm around underperforming companies in a certain industry and pressure them to change strategy. Right now, it’s biotech startups that are flush with cash but still years from successful drug approvals that are in the crosshairs.